| scholarly article | Q13442814 |
| P50 | author | Martin Bisaillon | Q88039706 |
| P2093 | author name string | Michelle S Scott | |
| Jean-Pierre Perreault | |||
| Philippe Thibault | |||
| Elvy Lapointe | |||
| Mathieu Durand | |||
| Simon Boudreault | |||
| Victoria E S Armero | |||
| Marie-Pier Tremblay | |||
| Andréa Allaire | |||
| Maude Tremblay-Létourneau | |||
| Camille Martenon-Brodeur | |||
| P2860 | cites work | bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death | Q24312157 |
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing | Q24321530 | ||
| Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis | Q24535499 | ||
| Tumor markers for hepatocellular carcinoma (Review) | Q24608195 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Aberrant RNA splicing and its functional consequences in cancer cells | Q24657594 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis | Q26782044 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Multiple sequence alignment with hierarchical clustering | Q27860956 | ||
| Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs | Q27934845 | ||
| Mechanisms of alternative pre-messenger RNA splicing | Q28131822 | ||
| Regulation of apoptosis by alternative pre-mRNA splicing | Q28259246 | ||
| Pfam: the protein families database | Q28660698 | ||
| Predictive and prognostic molecular markers for cancer medicine | Q28743108 | ||
| Understanding alternative splicing: towards a cellular code | Q29615085 | ||
| STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 | ||
| Pre-mRNA splicing and human disease | Q29617335 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| The CRAPome: a contaminant repository for affinity purification-mass spectrometry data | Q30660043 | ||
| The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events | Q33661198 | ||
| Pathogenesis of hepatitis B virus infection | Q33925491 | ||
| Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data | Q34125826 | ||
| DAVID-WS: a stateful web service to facilitate gene/protein list analysis | Q34250455 | ||
| Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection | Q34485074 | ||
| Prognostic prediction and treatment strategy in hepatocellular carcinoma. | Q34547469 | ||
| Viral hepatocarcinogenesis | Q34617749 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Identification of small molecule inhibitors of pre-mRNA splicing | Q35301222 | ||
| Cellular and molecular mechanisms of hepatocarcinogenesis | Q35532421 | ||
| Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas | Q35598151 | ||
| The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation | Q35736854 | ||
| The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. | Q35864702 | ||
| Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. | Q36006304 | ||
| Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage | Q36103898 | ||
| The gene encoding the splicing factor SF2/ASF is a proto-oncogene | Q36129226 | ||
| TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes | Q36434936 | ||
| Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43 | Q36966213 | ||
| A genecentric Human Protein Atlas for expression profiles based on antibodies | Q37231349 | ||
| Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. | Q37304724 | ||
| Tumor suppressors and cell metabolism: a recipe for cancer growth | Q37390879 | ||
| Experimental mouse models for hepatocellular carcinoma research | Q37574072 | ||
| Epithelial-mesenchymal transition in hepatocellular carcinoma. | Q37620382 | ||
| Hepatitis B and C virus-related carcinogenesis. | Q37623898 | ||
| Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). | Q38006770 | ||
| Redirecting splicing with bifunctional oligonucleotides. | Q38310108 | ||
| Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. | Q38964131 | ||
| Sudemycin E influences alternative splicing and changes chromatin modifications | Q39016007 | ||
| RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation | Q39044270 | ||
| Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 | ||
| Modulation of RNA splicing as a potential treatment for cancer | Q39427653 | ||
| Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. | Q39859123 | ||
| Multiple and specific mRNA processing targets for the major human hnRNP proteins | Q39958784 | ||
| ExPASy: SIB bioinformatics resource portal | Q42232951 | ||
| Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. | Q42718037 | ||
| The emerging role of splicing factors in cancer | Q43244074 | ||
| Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis. | Q46007909 | ||
| Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. | Q46535677 | ||
| Multiple alternative splicing markers for ovarian cancer | Q47568708 | ||
| Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. | Q51825138 | ||
| Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases | Q57981006 | ||
| Microarray analysis of gene expression during epithelial-mesenchymal transformation | Q80359005 | ||
| Energy deregulation: licensing tumors to grow | Q83854382 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 683 | |
| P577 | publication date | 2016-08-26 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma | |
| P478 | volume | 17 |
| Q92824666 | A Computational Analysis of Alternative Splicing across Mammalian Tissues Reveals Circadian and Ultradian Rhythms in Splicing Events |
| Q93355711 | A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer |
| Q58603892 | Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma |
| Q39416487 | Alternative RNA Splicing in the Pathogenesis of Liver Disease |
| Q61803766 | Deregulation of Circular RNAs in Cancer From the Perspectives of Aberrant Biogenesis, Transport and Removal |
| Q92128538 | Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors |
| Q91574624 | Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data |
| Q90072793 | Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability |
| Q92028316 | Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas |
| Q90267802 | Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer |
| Q91606325 | Viral modulation of cellular RNA alternative splicing: A new key player in virus-host interactions? |
| Q96304077 | Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma |
Search more.